News Daily News Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains Caitlin E. Cox December 31, 2025
News Daily News Patient-Centric Outcomes Embraced by Global Heart Valve Experts L.A. McKeown February 24, 2025
News Daily News STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios Yael L. Maxwell May 01, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024
News Daily News US and European Valvular Guidelines Mostly Concordant, Analysis Finds L.A. McKeown August 21, 2023
News Daily News Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes Michael O'Riordan September 13, 2022
News Daily News Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps Caitlin E. Cox January 25, 2022
News Daily News EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management L.A. McKeown September 22, 2021
News Daily News Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution L.A. McKeown January 22, 2021
News Daily News ‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease Michael O'Riordan August 06, 2018
News Daily News Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib Todd Neale March 15, 2017